enVVeno Medical Corp

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

NVNO$6.45-5.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of December 31, 2023 and 2022

BALANCE SHEETS

	December 31,
	2023	2022
(In thousands except par values, unless otherwise indicated)
Assets
Current Assets:
Cash and cash equivalents	$3,620	$4,555
Short-term investments	42,792	34,489
Prepaid expenses and other current assets	511	392
Total Current Assets	46,923	39,436
Property and equipment, net	334	521
Operating lease right-of-use assets, net	1,347	1,673
Security deposits and other assets	31	31
Total Assets	$48,635	$41,661
Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	$1,033	$1,216
Current portion of operating lease liabilities	338	314
Total Current Liabilities	1,371	1,530
Long-term operating lease liabilities	1,064	1,402
Total Liabilities	2,435	2,932
Commitments and Contingencies	-	-
Stockholders’ Equity:
Preferred stock, par value $0.00001, 10,000 shares authorized: no shares issued or outstanding	-	-
Common stock, par value $0.00001, 250,000 shares authorized, 13,317 and 9,472 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	-	-
Additional paid-in capital	176,236	145,249
Accumulated deficit	(130,036)	(106,520)
Total Stockholders’ Equity	46,200	38,729
Total Liabilities and Stockholders’ Equity	$48,635	$41,661

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.